(MedPage Today) — GLP-1 receptor agonists were tied to a lower risk of developing epilepsy in adults with type 2 diabetes, a large U.S. study showed.
Compared with DPP-4 inhibitors, GLP-1 receptor agonist use was associated with a 16% lower risk…
Global study reveals how psychedelics dissolve the brain’s hierarchy
New neuroimaging research suggests that multiple psychedelics affect the brain in a similar way, revealing something like the ‘core signature’...






